Moura Edmilson Leal Bastos de, Amorim Fábio Ferreira, Huang William, Maia Marcelo de Oliveira
Unidade de Terapia Intensiva, Hospital Santa Luzia - Brasília (DF), Brasil.
Escola Superior de Ciências da Saúde - Brasília (DF), Brasil.
Rev Bras Ter Intensiva. 2017 Jul-Sep;29(3):303-309. doi: 10.5935/0103-507X.20170041. Epub 2017 Sep 4.
To establish whether there is superiority between contrast-induced acute kidney injury and contrast-induced nephropathy criteria as predictors of unfavorable clinical outcomes.
Retrospective study carried out in a tertiary hospital with 157 patients undergoing radiocontrast infusion for propaedeutic purposes.
One hundred forty patients fulfilled the inclusion criteria: patients who met the criteria for contrast-induced acute kidney injury (59) also met the criteria for contrast-induced nephropathy (76), 44.3% met the criteria for KDIGO staging, 6.4% of the patients required renal replacement therapy, and 10.7% died.
The diagnosis of contrast-induced nephropathy was the most sensitive criterion for renal replacement therapy and death, whereas KDIGO showed the highest specificity; there was no correlation between contrast volume and progression to contrast-induced acute kidney injury, contrast-induced nephropathy, support dialysis or death in the assessed population.
确定对比剂诱导的急性肾损伤和对比剂肾病标准作为不良临床结局预测指标时是否存在优越性。
在一家三级医院开展回顾性研究，纳入157例因诊断目的接受放射性对比剂输注的患者。
140例患者符合纳入标准：符合对比剂诱导的急性肾损伤标准的患者（59例）也符合对比剂肾病标准（76例），44.3%符合KDIGO分期标准，6.4%的患者需要肾脏替代治疗，10.7%死亡。
对比剂肾病的诊断是肾脏替代治疗和死亡最敏感的标准，而KDIGO标准特异性最高；在评估人群中，对比剂用量与进展为对比剂诱导的急性肾损伤、对比剂肾病、支持性透析或死亡之间无相关性。
